Major depressive disorder
Tracked across 1 events · 6 articles · First seen May 28, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: The positive Phase 1b results for Zalsupindole offer hope for millions of patients suffering from Major depressive disorder, potentially addressing an unmet need for alternative treatments.
May 28, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Major depressive disorder live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard